Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
M.C. Walsh, E.K. Stork.
Persistent pulmonary hypertension of the newborn.
Clin Perinatol, 28 (2001), pp. 609-627
[2.]
R.H. Clark, T.J. Kueser, M.W. Walker, M.W. Southgate, J.L. Huckaby, J.A. Pérez, et al.
Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn.
N Engl J Med, 342 (2000), pp. 469-474
[3.]
J. Gianetti, S. Bevilacqua, R. De Caterina.
Inhaled nitric oxide: More than a selective pulmonary vasodilator.
Eur J Clin Invest, 32 (2002), pp. 628-635
[4.]
E. García Martínez, I. Ibarra De la Rosa, J.L. Pérez Navero, I. Tejero Mateo, J.F. Expósito Montes, J. Suárez de Lezo y Cruz Conde.
Sildenafilo en el tratamiento de la hipertensión pulmonar.
An Esp Pediatr, 59 (2003), pp. 110-113
[5.]
L.S. Shekerdemian, H.B. Ravn, D.J. Penny.
Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension.
Am J Respir Crit Care Med, 165 (2002), pp. 1098-1102
[6.]
W.D. Carroll, R. Dhillon.
Sildenafil as a treatment for pulmonary hypertension.
Arch Dis Child, 88 (2003), pp. 827-828
[7.]
E. Michelakis, W. Tymchak, D. Lien, L. Webster, K. Hashimoto, S. Archer.
Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: Comparison with inhaled nitric oxide.
Circulation, 105 (2002), pp. 2398-2403
[8.]
J.J. Lepore, A. Maroo, N.L. Pereira, L.C. Ginns, W.G. Dec, W.M. Zapol, et al.
Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension.
Am J Cardiol, 90 (2002), pp. 677-680
[9.]
S. Rite García, J.A. Ruiz Moreno, J. Sánchez Jimeno, M.I. Molin Chica, S. Marco Tello, S. Rite Montañes.
Óxido nítrico inhalado en el tratamiento de la hipertensión pulmonar persistente del recién nacido.
An Esp Pediatr, 51 (1999), pp. 181-185
Copyright © 2004. Asociación Española de Pediatría
